封面
市場調查報告書
商品編碼
1712617

2025年全球腫瘤消融設備市場報告

Tumor Ablation Therapy Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年腫瘤消融設備的市場規模將快速成長。預計到 2029 年將成長至 14.4 億美元,複合年成長率為 14.8%。預測期內的成長歸因於個人化醫療、聯合治療、人工智慧和影像引導消融、遠端醫療和遠距諮詢以及培訓和教育。預測期內的關鍵趨勢包括消融技術、影像引導、機器人和導航輔助、免疫腫瘤學整合、經皮消融和影像引導消融的進步。

由於癌症發生率的不斷上升,腫瘤消融設備市場正在不斷成長。癌症是導致死亡的主要原因,約佔全球癌症死亡人數的六分之一。腫瘤消融是一種微創手術,廣泛用於治療各種類型的腫瘤,包括肺癌、肝癌、腎臟癌和骨癌。例如,美國非營利醫療組織美國癌症協會估計,2023 年美國將新增約 1,958,310 例癌症病例,高於 2022 年的 1,918,030 例。這種治療方法正在支持腫瘤消融設備市場的成長,因為它提供了一種有效的治療選擇,特別是對於對化療和放射線治療沒有反應的患者。

預計微創手術需求的不斷成長將推動腫瘤消融設備市場的發展。微創手術涉及使用特殊工具和技術來最大限度地減少切口,從而減少對患者身體的傷害。腫瘤消融裝置在這些手術中發揮關鍵作用,它可以有效地破壞腫瘤,同時最大限度地減少對周圍組織的損害。例如,2023年1月,美國機器人產品製造商Intuitive Surgical Inc.報告稱,2022年使用達文西手術系統進行了約187.5萬例手術,較2021年的約159.4萬例成長18%。因此,微創手術需求的不斷成長預計將推動腫瘤消融設備市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤消融設備PESTEL分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 最終用途產業分析
  • 全球腫瘤消融設備市場:成長率分析
  • 全球腫瘤消融設備市場表現:規模與成長,2019-2024
  • 全球腫瘤消融設備市場預測:規模與成長,2024-2029 年,2034 年
  • 腫瘤消融設備的全球總目標市場(TAM)

第6章市場區隔

  • 全球腫瘤消融設備市場(按技術、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術
  • 微波消融
  • 冷凍療法
  • 不可逆電穿孔消融
  • 其他技術
  • 全球腫瘤消融設備市場按治療類型、表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 外科手術
  • 腹腔鏡檢查
  • 經皮
  • 全球腫瘤消融設備市場:按應用、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 腎癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 其他用途
  • 全球腫瘤消融設備市場(按最終用戶、性能和預測)2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 腫瘤診所
  • 其他最終用戶
  • 全球腫瘤消融設備市場,射頻消融術(RFA) 類型細分,表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 單極射頻消融裝置
  • 雙極射頻消融裝置
  • 全球腫瘤消融設備市場,依微波消融型細分,績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 高頻微波設備
  • 低頻微波設備
  • 全球腫瘤消融設備市場冷凍療法細分市場(按類型、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 基於液態氮的裝置
  • 基於氬氣的裝置
  • 全球不可逆電穿孔消融 (IRE) 腫瘤消融設備市場區隔(按類型)、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 奈米刀消融系統
  • 高壓脈衝發生器
  • 全球腫瘤消融設備市場細分(依其他技術類型、實際及預測),2019-2024 年、2024-2029 年、2034 年
  • 雷射消熔設備
  • 超音波導引高強度聚焦超音波(HIFU)
  • 化學消融技術

第7章 區域和國家分析

  • 全球腫瘤消融設備市場:依地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤消融設備市場:依國家、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • 腫瘤消融設備市場:競爭格局
  • 腫瘤消融設備市場:公司簡介
    • Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Medtronic plc
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • BVM Medical Limited
  • Erbe Elektromedizin GmbH
  • AtriCure Inc.
  • Theraclion
  • INTIO Inc.
  • BIOTRONIK SE & Co. KG
  • Olympus Corporation
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Insightec Ltd.
  • Terumo Corporation
  • Smith & Nephew plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年腫瘤消融設備市場:提供新機會的國家
  • 2029年腫瘤消融設備市場:細分市場帶來新機會
  • 2029年腫瘤消融設備市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32827

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.72 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

The rising demand for minimally invasive procedures is expected to propel the tumor ablation therapy devices market. Minimally invasive procedures involve specialized instruments and technology to minimize incisions, leading to less disruption to the patient's body. Tumor ablation therapy devices play a crucial role in these procedures by effectively destroying tumors while minimizing damage to surrounding tissues. For instance, in January 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, marking an 18% increase from the roughly 1,594,000 procedures conducted in 2021. Therefore, the growing demand for minimally invasive procedures is expected to drive the tumor ablation therapy devices market's growth.

Major companies in the tumor ablation therapy devices market are focusing on technological advancements to improve procedure efficiency, safety, reduce radiation exposure, shorten learning curves, and enhance patient outcomes. For instance, Compal Electronics, a Taiwan-based electronics manufacturing company, introduced AblatePal in April 2023, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, particularly non-resectable liver lesions. It employs electrical resistance to generate heat energy in the targeted tissue, resulting in its eradication. This system has applications in therapeutic medical devices, especially for cancer treatment.

Major companies are committed to developing minimally invasive therapies to gain a competitive edge in the market. Minimally invasive therapy is highly effective for tumor ablation, providing precise treatment with minimal disruption to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation aims to expedite the device's development and regulatory evaluation, potentially ensuring quicker patient access. The Vanquish system employs sterile water's thermal energy for precise cancer tissue treatment through a straightforward transurethral procedure, minimizing the risk of severe side effects associated with alternative prostate cancer therapies.

In August 2022, Imagin Medical, a Canada-based urologic oncology company, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from TROD Medical NV for $2.5 million. This acquisition strengthens Imagin's position as a urologic oncology company and broadens its portfolio in the field of prostate cancer. TROD Medical NV is a Belgium-based medical device company.

Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic PLC, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew PLC, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
  • 2) By Treatment: Surgical; Laparoscopic; Percutaneous
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Oncology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
  • 2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
  • 3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
  • 4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
  • 5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
  • Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Trends And Strategies

4. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Ablation Therapy Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Therapy Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM)

6. Tumor Ablation Therapy Devices Market Segmentation

  • 6.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • Other Technologies
  • 6.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical
  • Laparoscopic
  • Percutaneous
  • 6.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Clinics
  • Other End Users
  • 6.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monopolar RFA Devices
  • Bipolar RFA Devices
  • 6.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-frequency Microwave Devices
  • Low-frequency Microwave Devices
  • 6.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen-based Devices
  • Argon Gas-based Devices
  • 6.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NanoKnife Ablation Systems
  • High-voltage Pulse Generators
  • 6.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Ablation Devices
  • Ultrasound-guided High-intensity Focused Ultrasound (HIFU)
  • Chemical Ablation Techniques

7. Tumor Ablation Therapy Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Therapy Devices Market

  • 8.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Therapy Devices Market

  • 9.1. China Tumor Ablation Therapy Devices Market Overview
  • 9.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Therapy Devices Market

  • 10.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Therapy Devices Market

  • 11.1. Japan Tumor Ablation Therapy Devices Market Overview
  • 11.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Therapy Devices Market

  • 12.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Therapy Devices Market

  • 13.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Therapy Devices Market

  • 14.1. South Korea Tumor Ablation Therapy Devices Market Overview
  • 14.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Therapy Devices Market

  • 15.1. Western Europe Tumor Ablation Therapy Devices Market Overview
  • 15.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Therapy Devices Market

  • 16.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Therapy Devices Market

  • 17.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Therapy Devices Market

  • 18.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Therapy Devices Market

  • 19.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Therapy Devices Market

  • 20.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Therapy Devices Market

  • 21.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
  • 21.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Therapy Devices Market

  • 22.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Therapy Devices Market

  • 23.1. North America Tumor Ablation Therapy Devices Market Overview
  • 23.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Therapy Devices Market

  • 24.1. USA Tumor Ablation Therapy Devices Market Overview
  • 24.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Therapy Devices Market

  • 25.1. Canada Tumor Ablation Therapy Devices Market Overview
  • 25.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Therapy Devices Market

  • 26.1. South America Tumor Ablation Therapy Devices Market Overview
  • 26.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Therapy Devices Market

  • 27.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Therapy Devices Market

  • 28.1. Middle East Tumor Ablation Therapy Devices Market Overview
  • 28.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Therapy Devices Market

  • 29.1. Africa Tumor Ablation Therapy Devices Market Overview
  • 29.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Therapy Devices Market Competitive Landscape
  • 30.2. Tumor Ablation Therapy Devices Market Company Profiles
    • 30.2.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. EDAP TMS S.A.
  • 31.3. NeuWave Medical Inc.
  • 31.4. BVM Medical Limited
  • 31.5. Erbe Elektromedizin GmbH
  • 31.6. AtriCure Inc.
  • 31.7. Theraclion
  • 31.8. INTIO Inc.
  • 31.9. BIOTRONIK SE & Co. KG
  • 31.10. Olympus Corporation
  • 31.11. Stryker Corporation
  • 31.12. Merit Medical Systems Inc.
  • 31.13. Insightec Ltd.
  • 31.14. Terumo Corporation
  • 31.15. Smith & Nephew plc

32. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

34. Recent Developments In The Tumor Ablation Therapy Devices Market

35. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Therapy Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Therapy Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Therapy Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer